transparent gif
ImmuneSupport.com Home  
Fibromyalgia & Chronic Fatigue Syndrome:
Recently Published Research Abstracts
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

Recently Published Research Abstracts

  Abstracts: 1 - 10  (Total: 3960)
Date:                 Title:
05/14/08
  • Pain Ratings and Somatosensory Evoked Responses to Repetitive Intramuscular and Intracutaneous Stimulation in Fibromyalgia Syndrome – Source: Journal of Clinical Neurophysiology, May 8, 2008
    University of HeidelbergMultichannel EEG recordings tracking brain activity associated with electrical stimuli in the muscle & skin found Fibromyalgia patients were significantly more sensitive than health controls - with lower pain thresholds and tolerance levels. [Source: Journal of Clinical Neurophysiology, May 8, 2008]
  • 05/14/08
  • Sleep structure and sleepiness in Chronic Fatigue Syndrome with or without co-existing Fibromyalgia – Source: Arthritis Research & Therapy, May 2008
    A subset of ME/CFS patients was identified who are more sleepy/fatigued in the morning vs. a less sleepy subset. Polysomnograms indicated the more-sleepy symptom was associated with more-disrupted sleep - and not co-existing Fibromyalgia, RLS, sleep apnea, or different menstrual phase. [Source: Arthritis Research & Therapy, May 2008]
  • 05/12/08
  • S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial [ISRCTN36233495] – Source: BMC Musculoskeletal Disorders, Feb 2004
    The dietary supplement SAMe has a slower onset of action but supports improved comfort in knee osteoarthritis patients as effectively as the prescription NSAID drug celecoxib (brand name CelebrexR). [Source: BMC Musculoskeletal Disorders, Feb 2004]
  • 05/12/08
  • Arthritis as a potential barrier to physical activity among adults with diabetes: United States, 2005 and 2007 - Source: Morbidity and Mortality Weekly Report, May 2008
    A survey of U.S. adults with doctor-diagnosed diabetes determined that 52% also have diagnosed arthritis (45.9% of males & 58.0% of females with diabetes). Arthritis prevalence for the adult population overall is 21.6%. [Source: Morbidity and Mortality Weekly Report, May 2008]
  • 05/09/08
  • Curcumin and cancer: An ‘old-age’ disease with an ‘age-old’ solution – Source: Cancer Letters, May 5, 2008
    MD Anderson Cancer Center summarizes research indicating the potential benefits of curcumin to support the body’s defenses against various types of cancer (not to mention many other conditions, from arthritis and Alzheimer's to psoriasis). [Source: Cancer Letters, May 5, 2008]
  • 05/09/08
  • Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis – Source: Journal of Infectious Diseases, Apr 2008
    More on the findings of Jonathan Kerr (St. George’s University of London), et al. regarding seven identified gene expression subtypes of ME/CFS patients – as reported at the May 6, 2008 International Conference on ME/CFS Biomedical Research. [Source: Journal of Infectious Diseases, Apr 2008]
  • 05/09/08
  • Assessment of pain: A community-based diary survey in the USA – Source: The Lancet, May 2008
    National survey finds more than one-fourth of U.S. adults suffer daily pain; with some differences by economic status; calculates the national cost in lost productivity. [Source: The Lancet, May 2008]
  • 05/08/08
  • A Systematic Review of Chronic Fatigue Syndrome: Don’t Assume It’s Depression – Source: Primary Care Companion to the Journal of Clinical Psychiatry, #2, 2008
    Evidence review concludes "ME/CFS is underdiagnosed in more than 80% of the people who have it; and at the same time is often misdiagnosed as depression." Evaluating and managing it is challenging for physicians, and it's a challenging and difficult condition for patients. A bio-psycho-social approach to evaluation & management is recommended. [Source: Primary Care Companion to the Journal of Clinical Psychiatry, #2, 2008]
  • 05/08/08
  • Role of central dopamine in pain and analgesia - Source: Expert Review of Neurotherapeutics, May 2008
    Patrick B Wood's scientific update on the role of dopamine abnormalities/activity in central nervous system pain perception & pain relief for FM, Parkinson’s, RLS, etc. Continued research "may lead to the development of novel therapeutic strategies." [Source: Expert Review of Neurotherapeutics, May 2008]
  • 05/08/08
  • The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in Fibromyalgia syndrome and allied syndromes – Source: Joint, Bone, Spine, May 2, 2008
    Researchers are understanding increasingly that disturbances in the brain's sleep-wake cycle are a significant factor in FM pain & fatigue - along with a focus on medications to address them. [Source: Joint, Bone, Spine, May 2, 2008]

  • Click Here for More Fibromyalgia & Chronic Fatigue Syndrome Abstracts >>
    ©2008 ProHealth, Inc.
    (http://www.immunesupport.com)
    All Rights Reserved.
    transparent gif
    transparent gif transparent gif transparent gif

    Home | Library | Email Bulletins | Store | Community


    ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
    Email US or Call US at 1-800-366-6056
    Monday-Friday, 7 a.m.-5 p.m. PST
    International Callers can reach us at 001.805.564.3064
    Copyright © 2008 ProHealth, Inc.
    About us, Careers, Contact us, Privacy, 30-day Money Back Guarantee